Career thoughts and recollections: 50 years of publishing in the Journal of General Virology

References

1. Rowlands DJ, Cartwright B, Brown F. Evidence for an internal antigen in foot-and-mouth disease virus. J Gen Virol 1969; 4:479–487 [View Article]
   [Google Scholar]
2. Burroughs JN, Rowlands DJ, Sangar DV, Talbot P, Brown F. Further evidence for multiple proteins in the foot-and-mouth disease virus particle. J Gen Virol 1971; 13:73–84 [View Article]
   [Google Scholar]
3. Newman JF, Rowlands DJ, Brown F. A physico-chemical sub-grouping of the mammalian picornaviruses. J Gen Virol 1973; 18:171–180
   [Google Scholar]
4. Picornaviridae. http://www.picornaviridae.com/. 14 March 2019
5. Sangar DV, Black DN, Rowlands DJ, Brown F. Biochemical mapping of the foot-and-mouth disease virus genome. J Gen Virol 1977; 35:281–297 [View Article]
   [Google Scholar]
6. Bittle JL, Houghten RA, Alexander H, Shinnick TM, Sutcliffe JG et al. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 1982; 298:30–33 [View Article]
   [Google Scholar]
7. Acharya R, Fry E, Stuart D, Fox G, Rowlands D et al. The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature 1989; 337:709–716 [View Article]
   [Google Scholar]
8. Logan D, Abu-Ghazaleh R, Blakemore W, Curry S, Jackson T et al. Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 1993; 362:566–568 [View Article]
   [Google Scholar]
9. Francis MJ, Hastings GZ, Syred AD, McGinn B, Brown F et al. Non-Responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature 1987; 330:168–170 [View Article]
   [Google Scholar]
10. Clarke BE, Newton SE, Carroll AR, Francis MJ, Appleyard G et al. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein.. Nuc Acids Res 1987; 12:2461–2472
    [Google Scholar]
11. Rowlands DJ. Foot-and-mouth disease viruses. Encyclopedia of Virology 2, Third Edition. 2008 pp 265–274
    [Google Scholar]
12. Clarke BE, Sangar DV, Burroughs JN, Newton SE, Carroll AR et al. Two initiation sites for FMDV polyprotein in vivo. J.Gen.Virol 1985; 66:2615–2626
    [Google Scholar]
13. Newton SE, Carroll AR, Campbell RA, Clarke BE, Rowlands DJ. The sequence of FMDV RNA to the 5` side of the poly (C) tract. Gene 1985; 40:331–336
    [Google Scholar]
14. Clarke BE, Brown AL, Currey KM, Newton SE, Rowlands DJ et al. Potential secondary and tertiary structure in the genomic RNA of foot and mouth disease virus. Nucleic Acids Res 1987; 15:7067–7079 [View Article]
    [Google Scholar]
15. Choo QL, Weiner AJ, Overby LR, Kuo G, Houghton M et al. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990; 46:423–441 [View Article]
    [Google Scholar]
16. D'Souza ED, Grace K, Sangar DV, Rowlands DJ, Clarke BE. In vitro cleavage of hepatitis C virus polyprotein substrates by purified recombinant NS3 protease. J Gen Virol 1995; 76:1729–1736 [View Article]
    [Google Scholar]
17. Aoubala M, Holt J, Clegg RA, Rowlands DJ, Harris M. The inhibition of cAMP-dependent protein kinase by full-length hepatitis C virus NS3/4A complex is due to ATP hydrolysis. J Gen Virol 2001; 82:1637–1646 [View Article]
    [Google Scholar]
18. O'Farrell D, Trowbridge R, Rowlands D, Jäger J. Substrate complexes of hepatitis C virus RNA polymerase (HC-J4): structural evidence for nucleotide import and de-novo initiation. J Mol Biol 2003; 326:1025–1035 [View Article]
    [Google Scholar]
19. Griffin SDC, Beales LP, Clarke DS, Worsfold O, Evans SD et al. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, amantadine. FEBS Lett 2003; 535:34–38 [View Article]
    [Google Scholar]